Skip to main content
. 2020 Oct 18;17(18):2941–2946. doi: 10.7150/ijms.49297

Table 2.

Recurrent cancer patient diagnosis

AA (n=5) AG (n=8) GG (n=1) p value
Treatment*
CTx. 1 (14.3) 5 (71.4) 1 (14.3) 0.192
RTx. 4 (33.3) 7 (58.3) 1 (8.3) 0.852
HTx. 4 (33.3) 7 (58.3) 1 (8.3) 0.852
Type of recurrence 0.297
Local recurrence 4 (80.0) 2 (25.0) 1 (100)
Regional recurrence 0 1 (12.5) 0
Distant recurrence 1 (20.0) 5 (62.5) 0
Pathologic results 0.607
DCIS 2 (40.0) 2 (25.0) 0
IBC 2 (40.0) 2 (25.0) 1 (100)
Other breast cancer 1 (20.0) 1 (12.5) 0
Distant metastasis 0 3 (37.5) 0

Values are number of patients (%).

* Treatments were performed after breast cancer surgery. Pathologic results were confirmed by surgical biopsy after recurrent breast cancer was detected. DCIS: ductal carcinoma in situ; IBC: invasive breast cancer; CTx.: chemotherapy; RTx.: radiation therapy; HTx.: hormonal therapy.